microdosing with semaglutide GLP-1 Chart: Tirzepatide and GLP-1s | AgelessRx
Description
The practical protocols
Research shows these averages: 5% of body weight gone in about 12 weeks 10% or more lost in half a year Noticeable reduction in belly fat and smaller waistlines TrimBody M.D
HbA1c Reduction: In the SURPASS-2 trial, Mounjaro (15 mg) achieved a mean HbA1c reduction of 2.07% from baseline at week 40, compared to 1.89% for semaglutide 1 mg
In Part 1 we started discussing the study Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Weight Loss by Bartelt et al
Results tend to be better when the medication is combined with support for eating patterns, activity and sleep
